Clinical trial
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
NCT03103490 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT03103490 |
|---|---|
| Title | 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation |
| Official title | 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation |
| Lead sponsor | Stanford University, Other |
| Collaborators | GE Healthcare Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiac Sarcoidosis, Myocardial Inflammation |
| Intervention type | Drug |
| Interventions | 18F-FSPG |
| Enrollment | 45 |
| Start date | Aug 2, 2017 |
| Primary completion | Sep 28, 2021 |
| Completion | Sep 28, 2021 |
| First posted | Apr 6, 2017 |
| Last update posted | Apr 7, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: